These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35894540)

  • 1. α-Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid-Binding Property.
    Daida K; Shimonaka S; Shiba-Fukushima K; Ogata J; Yoshino H; Okuzumi A; Hatano T; Motoi Y; Hirunagi T; Katsuno M; Shindou H; Funayama M; Nishioka K; Hattori N; Imai Y
    Mov Disord; 2022 Oct; 37(10):2075-2085. PubMed ID: 35894540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase.
    Avenali M; Cerri S; Palmieri I; Ongari G; Stiuso R; Buongarzone G; Tassorelli C; Biagini T; Valente M; Cereda C; Mazza T; Gana S; Pacchetti C; Valente EM
    Mov Disord; 2024 Jun; 39(6):1060-1065. PubMed ID: 38436488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease-linked V15A mutation facilitates α-synuclein aggregation by reducing membrane affinity.
    Buratti FA; Fernández CO; Zweckstetter M
    Protein Sci; 2023 Aug; 32(8):e4693. PubMed ID: 37358478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease.
    Diaw SH; Borsche M; Streubel-Gallasch L; Dulovic-Mahlow M; Hermes J; Lenz I; Seibler P; Klein C; Brüggemann N; Vos M; Lohmann K
    NPJ Parkinsons Dis; 2023 Oct; 9(1):148. PubMed ID: 37903765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease.
    Fevga C; Park Y; Lohmann E; Kievit AJ; Breedveld GJ; Ferraro F; de Boer L; van Minkelen R; Hanagasi H; Boon A; Wang W; Petsko GA; Hoang QQ; Emre M; Bonifati V
    Parkinsonism Relat Disord; 2021 Aug; 89():63-72. PubMed ID: 34229155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.
    Hoffman-Zacharska D; Koziorowski D; Ross OA; Milewski M; Poznanski JA; Jurek M; Wszolek ZK; Soto-Ortolaza A; Awek JAS; Janik P; Jamrozik Z; Potulska-Chromik A; Jasinska-Myga B; Opala G; Krygowska-Wajs A; Czyzewski K; Dickson DW; Bal J; Friedman A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1057-1060. PubMed ID: 23916651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-associated mutations in α-synuclein alters its lipid-bound state.
    Maltseva S; Kerr D; Turke M; Adams EJ; Lee KYC
    Biophys J; 2024 Jun; 123(12):1610-1619. PubMed ID: 38702883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell.
    Matsuki A; Watanabe Y; Hashimoto S; Hoshino A; Matoba S
    Genes Cells; 2024 Apr; 29(4):328-336. PubMed ID: 38366711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease.
    Liu H; Koros C; Strohäker T; Schulte C; Bozi M; Varvaresos S; Ibáñez de Opakua A; Simitsi AM; Bougea A; Voumvourakis K; Maniati M; Papageorgiou SG; Hauser AK; Becker S; Zweckstetter M; Stefanis L; Gasser T
    Mov Disord; 2021 Jul; 36(7):1624-1633. PubMed ID: 33617693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein.
    Ohgita T; Namba N; Kono H; Shimanouchi T; Saito H
    Sci Rep; 2022 Apr; 12(1):6770. PubMed ID: 35474118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
    Zarbiv Y; Simhi-Haham D; Israeli E; Elhadi SA; Grigoletto J; Sharon R
    Neurobiol Dis; 2014 Oct; 70():90-8. PubMed ID: 24905915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
    Bodner CR; Maltsev AS; Dobson CM; Bax A
    Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxicities of A30P and A53T α-synuclein fibrils can be uniquely altered by the length and saturation of fatty acids in phosphatidylserine.
    Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
    J Biol Chem; 2023 Dec; 299(12):105383. PubMed ID: 37890776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.